Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

2.41 

-0.02 -0.8%

as of Jun 11 '21

52 Week Range:

1.60 5.00


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies worldwide. Its product portfolio includes aesthetic device platforms, including Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Velocity and Venus Epileve, a diode laser device for hair removal, permanent hair reduction, and treatment of ingrown hair; and Venus Fiore that is used for the treatment of vaginal canal, labia skin tightening, and mons pubis. The company also offers Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin; Venus Freeze Plus, a noninvasive device used in dermatologic and general surgical procedures for females for the noninvasive treatment of moderate to severe facial wrinkles and rhytides; Venus Bliss, a device is used for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance. In addition, it provides NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system; and ARTAS and ARTAS iX, a robotic systems to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. The company is headquartered in Toronto, Canada.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Equity (BVPS) -82.92
3.43
-0.76
0.66
growth rate 100.0% -100.0% 100.0%
Earnings BIT -6.47
12.80
4.93
-30.28
-30.48
growth rate 100.0% -61.5% -100.0% 0.0%
ROA -86.76
-93.53
-68.01
-89.85
-36.58
-48.50
growth rate 0.0% 0.0% 0.0% 0.0% 0.0%
ROE -388.82
-107.23
-144.03
growth rate 0.0% 0.0%
ROIC -114.73
-42.49
-61.09
growth rate 0.0% 0.0%
Cur. Ratio 5.12
1.37
2.26
3.14
2.07
3.55
growth rate -73.2% 65.0% 38.9% -34.1% 71.5%
Quick Ratio 3.75
1.10
1.95
2.42
1.58
2.79
growth rate -70.7% 77.3% 24.1% -34.7% 76.6%
Leverage 2.50
19.58
2.58
3.63
growth rate 683.2% -86.8% 40.7%
Balance Sheet Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Acct.Receivable 31.42
43.65
60.68
56.35
growth rate 38.9% 39.0% -7.1%
Acct.Payable 4.01
8.63
9.40
6.32
growth rate 115.4% 9.0% -32.8%
Cur.Assets 69.84
74.61
99.70
115.40
growth rate 6.8% 33.6% 15.8%
Total Assets 101.19
125.13
191.13
160.53
growth rate 23.7% 52.7% -16.0%
Cash 20.19
6.74
15.67
34.30
growth rate -66.6% 132.5% 118.9%
Inventory 13.34
20.26
18.84
17.76
growth rate 51.9% -7.0% -5.8%
Cur.Liabilities 18.20
30.07
48.17
32.52
growth rate 65.3% 60.2% -32.5%
Liabilities 58.43
88.68
114.45
116.76
growth rate 51.8% 29.1% 2.0%
LT Debt 35.26
50.89
61.23
77.25
growth rate 44.3% 20.3% 26.2%
Equity 39.95
32.43
74.18
44.23
growth rate -18.8% 128.7% -40.4%
Common Shares 2.00
2.00
49.98
2.00
9.00
37.00
growth rate 0.0% 2,398.9% -96.0% 350.0% 311.1%
Cash Flow Statement Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Capital Expenditures 1.00
1.53
1.16
1.12
0.29
growth rate 52.9% -24.4% -2.8% -74.1%
Cash Dividends -0.22
growth rate
Cash From OA -22.73
-18.88
-33.65
-39.60
-28.65
growth rate 0.0% 0.0% 0.0% 0.0%
FCF per Share -9.67
-10.02
-9.62
-1.40
growth rate 0.0% 0.0% 0.0%
FCF -25.00
-17.00
-19.00
-30.00
-41.00
-29.00
growth rate 0.0% 0.0% 0.0% 0.0% 0.0%
Income Statement Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Sales 53.14
89.07
102.61
110.41
78.01
growth rate 67.6% 15.2% 7.6% -29.3%
Op.Income -6.47
12.80
4.93
-30.28
-30.48
growth rate 100.0% -61.5% -100.0% 0.0%
IBT -12.10
7.88
-11.99
-40.44
-81.64
growth rate 100.0% -100.0% 0.0% 0.0%
Net Income -12.60
5.73
-14.96
-40.62
-81.71
growth rate 100.0% -100.0% 0.0% 0.0%
EPS -14.95
-14.22
-36.30
-12.90
-4.77
-2.33
growth rate 0.0% 0.0% 0.0% 0.0% 0.0%
Gross Profit 40.38
68.21
79.36
76.65
51.39
growth rate 68.9% 16.3% -3.4% -33.0%
R&D 4.69
5.68
7.05
8.03
7.75
growth rate 21.0% 24.1% 14.0% -3.5%

Quarterly Statements

Item Name Mar '20 Jun '20 Sep '20 Dec '20 Mar '21
Earnings BIT -16.13
-9.19
-3.09
-5.56
growth rate 0.0% 0.0% 0.0%
Balance Sheet Mar '20 Jun '20 Sep '20 Dec '20 Mar '21
Acct.Receivable 56.46
58.89
60.03
56.35
growth rate 4.3% 1.9% -6.1%
Acct.Payable 9.21
9.14
9.97
6.32
6.14
growth rate -0.8% 9.1% -36.6% -2.8%
Cur.Assets 100.47
100.10
100.13
115.40
106.68
growth rate -0.4% 0.0% 15.3% -7.6%
Total Assets 155.26
150.92
147.02
160.53
148.76
growth rate -2.8% -2.6% 9.2% -7.3%
Cash 20.63
14.03
12.78
34.30
26.99
growth rate -32.0% -8.9% 168.4% -21.3%
Inventory 18.92
19.03
19.49
17.76
17.99
growth rate 0.6% 2.4% -8.9% 1.3%
Cur.Liabilities 41.27
37.56
36.58
32.52
29.13
growth rate -9.0% -2.6% -11.1% -10.4%
Liabilities 108.68
110.59
110.37
116.76
112.81
growth rate 1.8% -0.2% 5.8% -3.4%
LT Debt 63.26
69.47
70.63
77.25
75.94
growth rate 9.8% 1.7% 9.4% -1.7%
Equity 44.81
39.18
35.58
44.23
36.60
growth rate -12.6% -9.2% 24.3% -17.3%
Common Shares 0.02
0.03
0.03
0.03
0.03
growth rate 4.2% 0.0% 4.0% 0.0%
Cash Flow Statement Mar '20 Jun '20 Sep '20 Dec '20 Mar '21
Capital Expenditures 0.06
0.05
0.10
0.08
0.05
growth rate -23.0% 112.8% -17.0% -36.1%
Cash Dividends -0.22
-0.22
-0.22
growth rate 0.0% 0.0%
Cash From OA -15.41
-9.31
-4.07
0.13
-8.22
growth rate 0.0% 0.0% 100.0% -100.0%
FCF -15.47
-9.35
-4.17
0.05
-8.27
growth rate 0.0% 0.0% 100.0% -100.0%
Income Statement Mar '20 Jun '20 Sep '20 Dec '20 Mar '21
Sales 14.51
17.00
20.68
25.83
22.60
growth rate 17.2% 21.7% 24.9% -12.5%
Op.Income -16.13
-9.19
-3.09
-5.56
growth rate 0.0% 0.0% 0.0%
IBT -50.11
-10.40
-8.29
-12.84
-9.44
growth rate 0.0% 0.0% 0.0% 0.0%
Net Income -50.19
-9.59
-7.24
-14.69
-9.26
growth rate 0.0% 0.0% 0.0% 0.0%
Gross Profit 9.28
11.90
13.50
16.71
15.23
growth rate 28.2% 13.5% 23.8% -8.8%
R&D 2.62
1.57
1.85
1.71
2.05
growth rate -40.2% 17.8% -7.5% 19.9%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

F (0.00)

YOY Growth Grade:

F (0.00)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

Current EPS is negative, therefore value price cannot be calculated.

PE and EPS

Historical Current Forward
PE -0.25
EPS / Growth -9.63

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 1.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 1.0% 1.0%
Future PE 0.01 0.01 0.67
Future EPS 0.00 0.00 0.00
Value Price
MOS %
0.00
-100.0%
0.00
-100.0%
0.00
-100.0%
MOS Price 0.00 0.00 0.00
IRT 99.00 99.00 99.00

Graham Number:

Current EPS is negative, therefore Graham Number cannot be calculated.
NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.